|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.5 USD | -2.29% |
|
-3.76% | -22.06% |
Dec 18 (Reuters) - Billionaire investor Carl Icahn said in a letter to the shareholders of Illumina that his goal was to remove legacy directors, just a day after the gene sequencing company decided to divest cancer test maker Grail.
(Reporting by Khushi Mandowara in Bengaluru; Editing by Arun Koyyur)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 108.5 USD | -2.29% | -3.76% | 17.69B | ||
| 16.66 USD | -1.01% | -9.31% | 7.59B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -22.06% | 17.69B | |
| +11.91% | 227B | |
| +15.46% | 197B | |
| +18.58% | 141B | |
| +30.36% | 110B | |
| +0.65% | 64.15B | |
| +17.74% | 53.72B | |
| +5.82% | 51.75B | |
| +11.23% | 45.2B | |
| +5.73% | 37.37B |
ILLUMINA, INC. 
